Mcgraw-hills Accessmedicine

FDA Approves New Protease Inhibitor for Salavage Therapy: Darunavir (TMC114)

Informações:

Sinopse

HOL Grand Rounds Lectures, HOL Updates, Hursts the Heart Updates